Investigations

The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the District of Maryland on behalf of those who acquired 2U, Inc. (“2U” or the “Company”) (NASDAQ: TWOU) securities during the period of February 9, 2022 through February 12, 2024, inclusive (“the Class Period”). Investors have until August 12, 2024 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
 

The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the District of Delaware on behalf of those who acquired 3D Systems Corporation (“3D Systems” or the “Company”) (NYSE:DDD) securities during the period of August 13, 2024 through May 12, 2025, inclusive (“the Class Period”). Investors have until August 12, 2025 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Middle District of Tennessee on behalf of those who acquired Acadia Healthcare Company, Inc. (“Acadia” or the “Company”) (NASDAQ: ACHC) securities during the period of February 28, 2020 to September 26, 2024, inclusive (“the Class Period”). Investors have until December 16, 2024 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
 

The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Central District of California on behalf of those who acquired Acelyrin, Inc.  (“Acelyrin” or the “Company) (NASDAQ: SLRN) securities during the period from May 4, 2023 through September 11, 2023, inclusive (the “Class Period”). Investors have until January 16, 2024 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Southern District of New York on behalf of those who acquired Actinium Pharmaceuticals, Inc. (“Actinium” or the “Company”) (NYSE:ATNM) securities during the period from October 31, 2022, through August 2, 2024 (“the Class Period”). Investors have until May 27, 2025, to apply to the Court to be appointed as lead plaintiff in the lawsuit.

The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Eastern District of Pennsylvania on behalf of those who acquired AdaptHealth Corp. (“AdaptHealth” or the “Company”) (NASDAQ: AHCO) securities during the period from August 4, 2020 through February 27, 2023, inclusive (the “Class Period”). Investors have until December 26, 2023 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Southern District of New York on behalf of those who acquired Adobe, Inc. (“Adobe” or the “Company”) (NASDAQ: ADBE) securities during the period from July 23, 2021 through September 15, 2022, inclusive (the “Class Period”). Investors have until December 19, 2023 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Eastern District of North Carolina on behalf of those who acquired Advance Auto Parts, Inc. (“AAP” or the “Company”) (NYSE: AAP) securities during the period from November 16, 2022 through May 30, 2023, inclusive (the “Class Period”). Investors have until December 8, 2023 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the District of Massachusetts on behalf of those who acquired Agenus, Inc. (“Agenus” or the “Company”) (NASDAQ: AGEN) securities during the period of January 1, 2023 through July 17, 2024, inclusive (“the Class Period”). Investors have until November 5, 2024 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Western District of Texas on behalf of those who acquired Agilon Health, Inc. (“Agilon” or the “Company”) (NYSE: AGL) securities during the period of April 15, 2021 through February 27, 2024, inclusive (“the Class Period”). Investors have until May 20, 2024 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Northern District of California on behalf of those who acquired Akero Therapeutics, Inc. (“Akero” or the “Company”) (NASDAQ: AKRO) securities during the period of September 13, 2022 through Ocober 9, 2023, inclusive (“the Class Period”). Investors have until June 25, 2024 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
 

The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the District of New Jersey on behalf of those who acquired Alarum Technologies Ltd. (“Alarum” or the “Company”) (NASDAQ:ALAR) securities during the period from March 14, 2024, through August 26, 2024 (“the Class Period”). Investors have until April 15, 2025, to apply to the Court to be appointed as lead plaintiff in the lawsuit.

The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Southern District of New York on behalf of those who acquired Allarity Therapeutics, Inc. ("Allarity" or the "Company") (NASDAQ: ALLR) securities during the period of May 17, 2022 to July 19, 2024 inclusive (the "Class Period"). Investors have until November 12, 2024 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

The law firm of Kirby McInerney LLP  announces that a class action lawsuit has been filed in the U.S. District Court for the District of Massachusetts on behalf of those who acquired AlloVir, Inc. (“AlloVir” or the “Company”) (NASDAQ: ALVR) securities during the period from March 22, 2022 through December 21, 2023, inclusive (the “Class Period”). Investors have until March 19, 2024 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
 

The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the District of Maryland on behalf of those who acquired Altimmune, Inc. (“ALT” or the “Company”) (NASDAQ: ALT) securities during the period of August 10, 2023 through June 25, 2024, inclusive (“the Class Period”). Investors have until October 6, 2025 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Norhtern District of California on behalf of those who acquired Alto Neuroscience, Inc. (“Alto Neuroscience” or the “Company”) (NYSE:ANRO) securities during the period of January 31, 2024 and October 22, 2024, inclusive (“the Class Period”). Investors have until September 19, 2025 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

The law firm of  Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Northern District of Texas on behalf of those who acquired American Airlines Group Inc. (“American” or the “Company”) (NASDAQ: AAL) securities during the period of January 25, 2024 through May 28, 2024 inclusive (“the Class Period”). Investors have until September 16, 2024 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
 

The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the District of Arizona on behalf of those who acquired AMMO Incorporated (“Ammo” or the “Company”) (NASDAQ: POWW) securities during the period of August 19, 2020 to September 24, 2024, inclusive (“the Class Period”). Investors have until November 29, 2024 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
 

The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Northern District of California on behalf of those who acquired Amplitude, Inc. (“Amplitude” or the “Company”) (NASDAQ: AMPL) securities during the period of September 21, 2021 to February 16, 2022 inclusive (“the Class Period”). Investors have until April 15, 2024 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Southern District of New York on behalf of those who acquired Amylyx Pharmaceuticals, Inc. (“Amylyx” or the “Company”) (NASDAQ:AMLX) securities during the period of November 11, 2022 to November 8, 2023, inclusive (“the Class Period”). Investors have until April 4, 2024 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Southern District of New York on behalf of those who acquired Anavex Life Scienecs Corporation  (“Anavex” or the “Company”) (NASDAQ:AVXL) securities during the period of February 1, 2022 to January 1, 2024, inclusive (“the Class Period”). Investors have until May 13, 2024 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Northern District of California on behalf of those who acquired Apple Inc. (“Apple” or the “Company”) (NASDAQ:AAPL) securities during the period from June 10, 2024, through June 9, 2025 (“the Class Period”). Investors have until August 19, 2025, to apply to the Court to be appointed as lead plaintiff in the lawsuit.
 

The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Southern District of New York on behalf of those who acquired Applied Therapeutics, Inc. (“Applied Therapeutics” or the “Company”) (NASDAQ:APLT) securities during the period from January 3, 2024 through and including December 2, 2024 (“the Class Period”). Investors have until February 18, 2025, to apply to the Court to be appointed as lead plaintiff in the lawsuit.

The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Northern District of California on behalf of those who acquired AppLovin Corporation (“AppLovin” or the “Company”) (NASDAQ:APP) securities during the period from May 10, 2023, through February 25, 2025 (“the Class Period”). Investors have until May 5, 2025, to apply to the Court to be appointed as lead plaintiff in the lawsuit.

The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Eastern District of New York on behalf of those who acquired Arbor Realty Trust, Inc. (“Arbor” or the “Company”) (NYSE: ABR) securities during the period of May 7, 2021 through July 11, 2024, inclusive (“the Class Period”). Investors have until September 30, 2024 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
 

The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Northern District of California on behalf of those who acquired Archer Aviation, Inc. (“Archer” or the “Company”) (NYSE: ACHR) securities during the period from September 17, 2021 through August 15, 2023, inclusive (the “Class Period”). Investors have until November 20, 2023 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Northern District of Illinois on behalf of those who acquired Archer-Daniels-Midland Company (“ADM” or the “Company”) (NYSE: ADM) securities during the period from April 30, 2020 through January 22, 2024, inclusive. Investors have until March 25, 2024 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Southern District of New York on behalf of those who sold Arconic Corporation (“Arconic” or the “Company”) (NYSE:ARNC) common stocks during the period from April 19, 2022, through May 3, 2023 (“the Class Period”). Investors have until March 31, 2025, to apply to the Court to be appointed as lead plaintiff in the lawsuit.

The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the District of Massachusetts on behalf of those who acquired Ardelyx, Inc. (“Ardelyx” or the “Company”) (NASDAQ: ARDX) securities during the period of October 31, 2023 to July 1, 2024, inclusive (“the Class Period”). Investors have until October 15, 2024 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Southern District of New York on behalf of those who acquired ASML Holding N.V. (“ASML” or the “Company”) (NASDAQ: ASML) securities during the period of January 24, 2024 to October 15, 2024, inclusive (“the Class Period”). Investors have until January 13, 2025, to apply to the Court to be appointed as lead plaintiff in the lawsuit.

The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Southern District of California on behalf of those who acquired ASP Isotopes Inc. (“ASP” or the “Company”) (NASDAQ:ASPI) securities during the period of October 30, 2024, to November 26, 2024, inclusive (“the Class Period”). Investors have until February 3, 2025, to apply to the Court to be appointed as lead plaintiff in the lawsuit.

The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Northern District of Illinois on behalf of those who acquired Assertio Holdings, Inc. (“Assertio” or the “Company”) (NASDAQ: ASRT) securities during the period from March 9, 2023 through November 8, 2023, inclusive. Investors have until March 5, 2024 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Central District of California on behalf of those who acquired AstraZeneca PLC (“AstraZeneca” or the “Company”) (NASDAQ:AZN) securities during the period from February 23, 2022, through December 17, 2024 (“the Class Period”). Investors have until February 21, 2025, to apply to the Court to be appointed as lead plaintiff in the lawsuit.